✦ LIBER ✦

Clinical trial: radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients

✍ Scribed by E. CORON; V. SEBILLE; G. CADIOT; F. ZERBIB; P. DUCROTTE; F. DUCROT; P. POUDEROUX; J. ARTS; M. LE RHUN; T. PICHE; S. BRULEY DES VARANNES; J. P. GALMICHE; CONSORTIUM DE RECHERCHE INDÉPENDANT SUR LE TRAITEMENT ET L’EXPLORATION DU REFLUX GASTRO-OESOPHAGIEN ET DE L’ENDOBRACHYOESOPHAGE (CRITERE)

Book ID: 108605416
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 372 KB
Volume: 28
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2008.03790.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sub-optimal proton pump inhibitor dosing

Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease

✍ N. T. GUNARATNAM; T. P. JESSUP; J. INADOMI; D. P. LASCEWSKI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Oesophageal and gastric pH profiles in p

Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors

✍ L. B. Gerson; V. Boparai; N. Ullah; G. Triadafilopoulos 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Randomised clinical trial: effects of mo

Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease

✍ F. Zerbib; S. Bruley des Varannes; S. Roman; R. Tutuian; J.-P. Galmiche; F. Mion 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

The 12-month safety profile of dexlansop

The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease

✍ A. H. Dabholkar; C. Han; M. M. Paris; M. C. Perez; S. N. Atkinson; D. A. Peura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Comparison of risk factors and clinical

Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease

✍ E. S. LEE; N. KIM; S. H. LEE; Y. S. PARK; J. W. KIM; S. H. JEONG; D. H. LEE; H. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Systematic review: the association betwe

Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease

✍ A. Becher; H. El-Serag 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB